Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11127)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2016 (publication date) through Jul 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li YW, Yang FC, Lu HQ, Zhang JS. Hepatocellular carcinoma and hepatitis B surface protein. World J Gastroenterol 2016; 22(6): 1943-1952 [PMID: 26877602 DOI: 10.3748/wjg.v22.i6.1943] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i6/1943.htm |
| Number | Citing Articles |
| 1 |
Miao Liu, Lingyao Du, Zhiliang He, Libo Yan, Ying Shi, Jin Shang, Hong Tang. Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1252647
|
| 2 |
Tomohiro Nishikawa, Masahiro Matsui, Saori Onishi, Kosuke Ushiro, Akira Asai, Soo-Ki Kim, Hiroki Nishikawa. Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B. International Journal of Molecular Sciences 2024; 25(4): 2245 doi: 10.3390/ijms25042245
|
| 3 |
Liuqing Yang, Qiang Wang, Tingting Cui, Jinxin Huang, Hui Jin, Stefano Gitto. Reporting and Performance of Hepatocellular Carcinoma Risk Prediction Models: Based on TRIPOD Statement and Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9996358
|
| 4 |
Matthias Buechter, Arne Maria Günther, Paul Manka, Guido Gerken, Alisan Kahraman. Factors Positively Correlated with Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B. Journal of Personalized Medicine 2024; 14(4): 390 doi: 10.3390/jpm14040390
|
| 5 |
Christopher A. Dietz, Heiner Wedemeyer. Rolle der Hepatitis-B-Impfung in der Prävention des hepatozellulären Karzinoms. Der Onkologe 2022; 28(1): 15 doi: 10.1007/s00761-021-01036-0
|
| 6 |
Julian Musa, Jing Li, Thomas GP Grünewald. Hepatitis B virus large surface protein is priming for hepatocellular carcinoma development via induction of cytokinesis failure. The Journal of Pathology 2019; 247(1): 6 doi: 10.1002/path.5169
|
| 7 |
Ming Wang, Dong Xi, Qin Ning. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatology International 2017; 11(2): 171 doi: 10.1007/s12072-016-9779-5
|
| 8 |
Lilian Yan Liang, Vincent Wai-Sun Wong, Hidenori Toyoda, Yee-Kit Tse, Terry Cheuk-Fung Yip, Becky Wing-Yan Yuen, Toshifumi Tada, Takashi Kumada, Hye-Won Lee, Grace Chung-Yan Lui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong. Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients. Journal of Gastroenterology 2020; 55(9): 899 doi: 10.1007/s00535-020-01700-z
|
| 9 |
Bingyan Hao, Yachong Liu, Bohan Wang, Haofeng Wu, Yan Chen, Lei Zhang. Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma. Experimental Hematology & Oncology 2025; 14(1) doi: 10.1186/s40164-025-00642-7
|
| 10 |
Jianhua Li, Wenzhi Guo, Wenping Xue, Pengfei Xu, Zhen Deng, Danhua Zhang, Shouhua Zheng, Xinguang Qiu. Long noncoding RNA AURKAPS1 potentiates malignant hepatocellular carcinoma progression by regulating miR-142, miR-155 and miR-182. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56036-3
|
| 11 |
L.A. Romano, M.da C. Klosterhoff, A.F.F. de Medeiros, S. Oliveira, V.F. Pedrosa. Occurrence of hepatocellular carcinoma in wild pejerrey Odontesthes bonariensis (Teleostei, Atherinidae). Bulletin of the European Association of Fish Pathologists 2022; 41(6) doi: 10.48045/001c.36981
|
| 12 |
Jing-Jing Han, Yu-An Hu, Yuchen Nan, Yu Chen, Yong-Lin Yang. Decreased expression of HBV surface antigen (HBsAg) with sK122R and sV96A co-mutation is associated with an ineffective antibody response in a chronic hepatitis B patient. Infection, Genetics and Evolution 2023; 111: 105431 doi: 10.1016/j.meegid.2023.105431
|
| 13 |
Weidong Zhao, Gan Zhao, Shuren Zhang, Xianzheng Wang, Xueping Yu, Bin Wang. Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-α as an effective therapeutic vaccine adjuvant. Oncotarget 2018; 9(76): 34213 doi: 10.18632/oncotarget.25789
|
| 14 |
Zainab M.A. Anis, Amira Y. Ahmed, Hanan H. Soliman, Hala M. Nagy. Serum growth differentiation factor 15 levels as a marker for liver cirrhosis and hepatocellular carcinoma on top of liver cirrhosis. Tanta Medical Journal 2022; 50(4): 251 doi: 10.4103/tmj.tmj_173_20
|
| 15 |
Mohammad Darvishi, Majid Nouri, Rasoul Rahimi, Saeid Heidari-Soureshjani, Seyed Mahmoud Reza Hashemi Rafsanjani. A Systematic Review of the Impact of Resveratrol on Viral Hepatitis and Chronic Viral Hepatitis-related Hepatocellular Carcinoma. Current Molecular Medicine 2025; 25(5): 589 doi: 10.2174/0115665240284347240125072555
|
| 16 |
Citrawati Dyah Kencono Wungu, Fis Citra Ariyanto, Gwenny Ichsan Prabowo, Soetjipto Soetjipto, Retno Handajani. Meta‐analysis: Association between hepatitis B virus preS mutation and hepatocellular carcinoma risk. Journal of Viral Hepatitis 2021; 28(1): 61 doi: 10.1111/jvh.13402
|
| 17 |
Hai Huang, Wei Zhou, Haiyan Zhu, Pei Zhou, Xunlong Shi. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs. Toxicology and Applied Pharmacology 2017; 323: 36 doi: 10.1016/j.taap.2017.03.016
|
| 18 |
Habibollah Mirzaei, Ebrahim Faghihloo. Viruses as key modulators of the TGF‐β pathway; a double‐edged sword involved in cancer. Reviews in Medical Virology 2018; 28(2) doi: 10.1002/rmv.1967
|
| 19 |
Yan Du, Xue Han, Yi-Bo Ding, Jian-Hua Yin, Guang-Wen Cao. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects. World Journal of Gastroenterology 2016; 22(29): 6565-6572 doi: 10.3748/wjg.v22.i29.6565
|
| 20 |
Atanasio Pandiella-Alonso, Elena Díaz-Rodríguez, Eduardo Sanz. Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review. Nutrients 2020; 12(9): 2661 doi: 10.3390/nu12092661
|
| 21 |
Pei-song Bai, Peng Hou, Ying Kong. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway. Experimental Cell Research 2018; 370(1): 174 doi: 10.1016/j.yexcr.2018.06.020
|
| 22 |
Amanda K. McCullough, R. Stephen Lloyd. Mechanisms underlying aflatoxin-associated mutagenesis – Implications in carcinogenesis. DNA Repair 2019; 77: 76 doi: 10.1016/j.dnarep.2019.03.004
|
| 23 |
Huai‐Lung Chang, Wan‐Hsin Wen, Chien‐Nan Lee, Yu‐En Chiu, Chun‐Jen Liu, Mei‐Hwei Chang, Lung‐Huang Lin, Huey‐Ling Chen. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate. Journal of Viral Hepatitis 2022; 29(2): 107 doi: 10.1111/jvh.13628
|
| 24 |
Daxiang Zhou, Ling Dong, Lishan Yang, Qiang Ma, Feng Liu, Yanjie Li, Shu Xiong. Identification and analysis of circRNA–miRNA–mRNA regulatory network in hepatocellular carcinoma. IET Systems Biology 2020; 14(6): 391 doi: 10.1049/iet-syb.2020.0061
|
| 25 |
Chun-Chen Wu, Ying-Shan Chen, Liang Cao, Xin-Wen Chen, Meng-Ji Lu. Hepatitis B virus infection: Defective surface antigen expression and pathogenesis. World Journal of Gastroenterology 2018; 24(31): 3488-3499 doi: 10.3748/wjg.v24.i31.3488
|
| 26 |
Bei Wang, Shengjin Ge, Wanxia Xiong, Zhanggang Xue. Effects of resveratrol pretreatment on endoplasmic reticulum stress and cognitive function after surgery in aged mice. BMC Anesthesiology 2018; 18(1) doi: 10.1186/s12871-018-0606-5
|
| 27 |
Yuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Taisuke Inoue, Tadashi Sato, Minoru Sakamoto, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto, Jason Blackard. HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers. PLOS ONE 2019; 14(2): e0212559 doi: 10.1371/journal.pone.0212559
|
| 28 |
Elham Shirvani-Dastgerdi, Robert E Schwartz, Alexander Ploss. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Current Opinion in Virology 2016; 20: 1 doi: 10.1016/j.coviro.2016.07.009
|
| 29 |
Shahrzad Shoraka, Seyed Mahdi Hosseinian, Ayda Hasibi, Amir Ghaemi, Seyed Reza Mohebbi. The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1213145
|
| 30 |
Kirstine Overgaard Nielsen, Aashiq Hussain Mirza, Simranjeet Kaur, Kari Stougaard Jacobsen, Thilde Nordmann Winther, Dieter Glebe, Flemming Pociot, Birthe Hogh, Joachim Størling. Hepatitis B virus suppresses the secretion of insulin-like growth factor binding protein 1 to facilitate anti-apoptotic IGF-1 effects in HepG2 cells. Experimental Cell Research 2018; 370(2): 399 doi: 10.1016/j.yexcr.2018.07.002
|
| 31 |
Rajiv Kumar Mondal, Mousumi Khatun, Priyanka Banerjee, Alip Ghosh, Sumanta Sarkar, Amal Santra, Kausik Das, Abhijit Chowdhury, Soma Banerjee, Simanti Datta. Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriers. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09965-w
|
| 32 |
Seyed Y. Hosseini, Neda Sanaei, Mohamad-Reza Fattahi, Seyed A. Malek-Hosseini, Jamal Sarvari. Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients. Annals of Hepatology 2019; 18(4): 640 doi: 10.1016/j.aohep.2018.12.006
|
| 33 |
Tengyue Hu, Jiayi Wang, Weixiu Li, Miao Liu, Ning Han, Man Yuan, Lingyao Du, Hong Tang. Endoplasmic Reticulum Stress in Hepatitis B Virus and Hepatitis C Virus Infection. Viruses 2022; 14(12): 2630 doi: 10.3390/v14122630
|
| 34 |
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
|
| 35 |
Na Qiu, Akshaya Srikanth, Medhanie Mulaw, Umesh Tharehalli, Shanthiya Selvachandran, Martin Wagner, Thomas Seufferlein, Katja Stifter, André Lechel, Reinhold Schirmbeck. CD8 T cell-mediated depletion of HBV surface-antigen-expressing, bilineal-differentiated liver carcinoma cells generates highly aggressive escape variants. OncoImmunology 2023; 12(1) doi: 10.1080/2162402X.2023.2215096
|
| 36 |
Yaming Liu, Jessica L. Maiers, Yajuan Rui, Xiaoming Jiang, Bayasi Guleng, Jianlin Ren. Apolipoprotein H drives hepatitis B surface antigen retention and endoplasmic reticulum stress during hepatitis B virus infection. The International Journal of Biochemistry & Cell Biology 2021; 131: 105906 doi: 10.1016/j.biocel.2020.105906
|
| 37 |
Guannan Wang, Xiaosan Fang, Meng Han, Xiaoming Wang, Qiang Huang. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3358
|
| 38 |
Jing Tang, Li-Juan Zhang, Min Kang, Rong Huang, Hui-Ye Shu, Hong Wei, Jie Zou, Yi-Cong Pan, Qian Ling, Yi Shao. AFP and CA-125 as an accurate risk factor to predict eye metastasis in hypertension patients with liver carcinoma: A STROBE-compliant article. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1010903
|
| 39 |
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and Pathogenesis. Journal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
|
| 40 |
Yuno Nishida, Michio Imamura, Yuji Teraoka, Kei Morio, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Akira Hiramatsu, Hiromi Abe‐Chayama, C. Nelson Hayes, Hiroshi Aikata, Noriko Sasaki, Tomomi Sekiguchi, Hideki Kinukawa, Toru Yoshimura, Kazuaki Chayama. Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients. Journal of Viral Hepatitis 2021; 28(9): 1304 doi: 10.1111/jvh.13557
|
| 41 |
Haiyan Li, Fuchu Qian, Weihua Zou, Fang Jin, Dongli Li, Yaqin Zhang. Seroprevalence and mutations in the major hydrophilic region of hepatitis B virus among pregnant women in Huzhou, China. Transactions of The Royal Society of Tropical Medicine and Hygiene 2022; 116(9): 874 doi: 10.1093/trstmh/trac040
|
| 42 |
Feilin Ge, Yan Yang, Zhaofang Bai, Lanlan Si, Xuemei Wang, Jia Yu, Xiaohe Xiao, Yan Liu, Zhigang Ren. The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges. Chinese Medicine 2023; 18(1) doi: 10.1186/s13020-023-00861-2
|
| 43 |
Wai Yeow Lee, Maulana Bachtiar, Cheryl C. S. Choo, Caroline G. Lee. Comprehensive review of Hepatitis B Virus‐associated hepatocellular carcinoma research through text mining and big data analytics. Biological Reviews 2019; 94(2): 353 doi: 10.1111/brv.12457
|
| 44 |
Natalia Freitas, Tetyana Lukash, Sumedha Gunewardena, Benjamin Chappell, Betty L. Slagle, Severin O. Gudima, Rozanne M. Sandri-Goldin. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers. Journal of Virology 2018; 92(10) doi: 10.1128/JVI.02221-17
|
| 45 |
Wenqi Song, Xuemei Zhang, Lin Feng, Yongwei Lai, Tongtong Li, Pengxia Zhang. Downregulated lncRNA SNHG18 Suppresses the Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Meditates the Antitumor Effect of Oleanolic Acid. Cancer Management and Research 2022; : 687 doi: 10.2147/CMAR.S346920
|
| 46 |
Jie Wang, Kaijie Qiu, Songsheng Zhou, Yichao Gan, Keting Jiang, Donghuan Wang, Haibiao Wang. Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis. Annals of Medicine 2025; 57(1) doi: 10.1080/07853890.2025.2455539
|
| 47 |
Dowluru S.V.G.K. Kaladhar, Tantravahi Srinivasan. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 257 doi: 10.1016/B978-0-323-98806-3.00005-2
|